India, Feb. 25 -- While reporting its results for the fourth quarter, USANA Health Sciences, Inc. (USNA) reported outlook for the full year 2025.
The company reported consolidated net sales between $920 million and $1.0 billion, or 8% - 17% growth. Net earnings between $29 million and $41 million or earnings per share between $1.50 and $2.20.
Adjusted EPS is expected to be between $2.35 and $3.00. Adjusted EBITDA is expected between $107 million and $123 million.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
CEO Jim Brown said, "Our growth strategy for the direct sales business in 2025 is centered on our Associate sales force and providing them with the resources needed to generate sustainable acti...